Natalie S. Callander, MD, on Maneuvering the Complex Web of Treatment Options for Multiple Myeloma

Posted: Monday, November 22, 2021

Natalie S. Callander, MD, of the University of Wisconsin Carbone Cancer Center, discusses the many treatment options now available for patients with relapsed or refractory multiple myeloma and how this setting is further complicated by factors including previous treatments, patient comorbidities, age, and previous responses. She offers clinical pearls on how to approach these complexities.